JILL SADOWSKI: Open Payments
NPI 1770135279 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 6 payments from 5 companies in 2025. Trend: 2023 $59 · 2024 $525 · 2025 $546
Food & beverage: $546
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $245 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $31 |
| TerSera Therapeutics LLC | 1 | $22 |
Products named: BREYANZI, LYNOZYFIC, JEMPERLI, REBLOZYL, Trodelvy, Zoladex.
Industry payments across NY — which companies pay providers there.
